Novel aspects of G-protein-coupled receptor signalling - Different ways to achieve specificity

Acta Physiologica

Volumn 190, Issue 1, 2007, Pages 33-38

  Schulte, G ^a   Levy, F O ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

arrestin; Biased agonism; Co receptors; Heterotrimeric G proteins; Receptor dimerization; Signalling trafficking

Indexed keywords

BETA ARRESTIN; DISHEVELLED PROTEIN; FRIZZLED PROTEIN; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR; WNT3A PROTEIN;

CONFERENCE PAPER; DIMERIZATION; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; RECEPTOR CROSS-TALK; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 34147161691     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2007.01696.x     Document Type: Conference Paper

References (40)

1. Bryja, V., Schulte, G. & Arenas, E. 2006. Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin. Cell Signal 19, 610-616.
2. Bryja, V., Schulte, G., Rawal, N., Grahn, A. & Arenas, E. 2007. Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism. J Cell Sci 120, 586-595.
3. Bulenger, S., Marullo, S. & Bouvier, M. 2005. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26, 131-137.
4. Burgering, B.M., Pronk, G.J., van Weeren, P.C., Chardin, P. & Bos, J.L. 1993. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.EMBO J 12, 4211-4220.
5. s-cAMP-mediated inhibition. J Biol Chem 270, 25259-25265.
6. Dumont, J.E., Pécasse, F. & Maenhaut, C. 2001. Crosstalk and specificity in signalling. Are we crosstalking ourselves into general confusion? Cell Signal 13, 457-463.
7. Enserink, J.M., Christensen, A.E., de Rooij, J. et al. 2002. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4, 901-906.
8. Foord, S.M., Bonner, T.I., Neubig, R.R. et al. 2005. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57, 279-288.
9. Fu, Y., Zhong, H., Nanamori, M. et al. 2004. RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins. Methods Enzymol 389, 229-243.
10. Fu, Y., Huang, X., Zhong, H., Mortensen, R.M., D'Alecy, L.G. & Neubig, R.R. 2006. Endogenous RGS proteins and Gα subtypes differentially control muscarinic and adenosinemediated chronotropic effects. Circ Res 98, 659-666.
11. Galés, C., Van Durm, J.J., Schaak, S. et al. 2006. Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 13, 778-786.
12. Graves, L.M., Bornfeldt, K.E., Raines, E.W. et al. 1993. Protein kinase A antagonizes platelet-derived growth factorinduced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA 90, 10300-10304.
13. Gutkind, J.S. 2000. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000, RE1.
14. He, X., Semenov, M., Tamai, K. & Zeng, X. 2004. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131, 1663-1677.
15. Hein, P., Frank, M., Hoffmann, C., Lohse, M.J. & Bünemann, M. 2005. Dynamics of receptor/G protein coupling in living cells. EMBO J 24, 4106-4114.
16. Huang, X., Fu, Y., Charbeneau, R.A. et al. 2006. Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele. Mol Cell Biol 26, 6870-6879.
17. Keeble, T.R., Halford, M.M., Seaman, C. et al. 2006. The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum. J Neurosci 26, 5840-5848.
18. s-coupled receptors. J Biol Chem 279, 46497-46508.
19. Kenakin, T. 1995. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci 16, 232-238.
20. Kenakin, T. 2003. Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol Sci 24, 346-354.
21. Kikuchi, A. & Williams, L.T. 1996. Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase. J Biol Chem 271, 588-594.
22. 7 serotonin receptor splice variants: constitutive activity and inverse agonist effects. Br J Pharmacol 135, 1563-1571.
23. 7 serotonin receptor. Eur J Pharmacol 532, 1-10.
24. Luttrell, L.M. 2006. Transmembrane signaling by G proteincoupled receptors. Methods Mol Biol 332, 3-49.
25. Marinissen, M.J. & Gutkind, J.S. 2001. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22, 368-376.
26. Mischak, H., Seitz, T., Janosch, P. et al. 1996. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol Cell Biol 16, 5409-5418.
27. Neubig, R.R. & Siderovski, D.P. 2002. Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 1, 187-197.
28. 7(a). J Biol Chem 278, 3098-3104.
29. Norum, J.H., Méthi, T., Mattingly, R.R. & Levy, F.O. 2005. Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells. FEBS J 272, 2304-2316.
30. s-coupled receptor stimulation in HEK293 cells. FEBS Lett 581, 15-20.
31. Oishi, I., Suzuki, H., Onishi, N. et al. 2003. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645-654.
32. Pierce, K.L., Premont, R.T. & Lefkowitz, R.J. 2002. Seventransmembrane receptors. Nat Rev Mol Cell Biol 3, 639-650.
33. 2B receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp Cell Res 290, 168-176.
34. Sevetson, B.R., Kong, X. & Lawrence, J.C. 1993. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 90, 10305-10309.
35. Sexton, P.M., Morfis, M., Tilakaratne, N. et al. 2006. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs. Ann NY Acad Sci 1070, 90-104.
36. Vossler, M.R., Yao, H., York, R.D., Pan, M.G., Rim, C.S. & Stork, P.J. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89, 73-82.
37. Wei, H., Ahn, S., Shenoy, S.K. et al. 2003. Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100, 10782-10787.
38. Willins, D.L., Berry, S.A., Alsayegh, L. et al. 1999. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience 91, 599-606.
39. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M.J. & Sturgill, T.W. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262, 1065-1069.
40. Zhai, P., Yamamoto, M., Galeotti, J. et al. 2005. Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice. J Clin Invest 115, 3045-3056.